Patents by Inventor Brian Shields

Brian Shields has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12484957
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: April 7, 2025
    Date of Patent: December 2, 2025
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 12446953
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: June 23, 2025
    Date of Patent: October 21, 2025
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Publication number: 20250312090
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Application
    Filed: June 23, 2025
    Publication date: October 9, 2025
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Publication number: 20250312089
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Application
    Filed: June 23, 2025
    Publication date: October 9, 2025
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Publication number: 20250312088
    Abstract: The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The method includes providing a treatment device comprising a treatment comprising a plurality of electrodes and advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element are positioned relative to targeted neural tissue within the nasal cavity. The method further includes controlling, via a console unit operably coupled to the treatment device, delivery of one or more treatment applications applied via the treatment element for altering transmission of signals through the targeted tissue.
    Type: Application
    Filed: June 23, 2025
    Publication date: October 9, 2025
    Inventors: David Townley, Brian Shields
  • Publication number: 20250281230
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Application
    Filed: April 7, 2025
    Publication date: September 11, 2025
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Publication number: 20250255666
    Abstract: The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The method includes providing a treatment device comprising a treatment comprising a plurality of electrodes and advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element are positioned relative to targeted neural tissue within the nasal cavity. The method further includes controlling, via a console unit operably coupled to the treatment device, delivery of one or more treatment applications applied via the treatment element for altering transmission of signals through the targeted tissue.
    Type: Application
    Filed: April 21, 2025
    Publication date: August 14, 2025
    Inventors: David Townley, Brian Shields
  • Patent number: 12279808
    Abstract: The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The system includes a device including a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient. The multi-segment end effector includes a first segment and a separate second segment, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration, the first segment having a first geometry when in the deployed configuration to complement anatomy at a first location within the nasal cavity and a second segment having a second geometry when in the deployed configuration to complement anatomy at a second location within the nasal cavity.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: April 22, 2025
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 12268433
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: May 30, 2024
    Date of Patent: April 8, 2025
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Publication number: 20240307110
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Application
    Filed: May 30, 2024
    Publication date: September 19, 2024
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 12082872
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: September 10, 2024
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 12004800
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 11, 2024
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11771497
    Abstract: Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: October 3, 2023
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 11701167
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: July 18, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11690672
    Abstract: A device for therapeutic neuromodulation in a nasal region can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: July 4, 2023
    Assignee: National University of Ireland, Galway
    Inventors: David Townley, Brian Shields, Ivan Keogh, Michele Qi Zhan, Conor Farrell
  • Patent number: 11684414
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 27, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11666378
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 6, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11576719
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: February 14, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547473
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547472
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields